CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-748 Cr | ₹-591 Cr | ₹-403 Cr | ₹-293 Cr | ₹-205 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of CIPLA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹-748 Cr |
| Mar2025 | ₹-591 Cr |
| Mar2024 | ₹-403 Cr |
| Mar2023 | ₹-293 Cr |
| Mar2022 | ₹-205 Cr |
How is Deferred Tax Assets / Liabilities of CIPLA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-748 Cr | Negative | |
| Mar2025 | ₹-591 Cr | Negative | |
| Mar2024 | ₹-403 Cr | Negative | |
| Mar2023 | ₹-293 Cr | Negative | |
| Mar2022 | ₹-205 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹114,168.4 Cr | -0.5% | -2.5% | -10.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹463,791.0 Cr | 1.7% | -1.4% | 21.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,081.0 Cr | 2% | 10.3% | 49.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,351.0 Cr | -0.4% | -0.5% | 38.6% | Stock Analytics | |
| MANKIND PHARMA | ₹98,304.7 Cr | -1.5% | -3.3% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.3 Cr | -1.2% | 0% | -7.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.5% |
-2.5% |
-10.2% |
| SENSEX | -1.2% |
-2.6% |
-5.2% |
You may also like the below Video Courses